Details
Further details
-
Experience
- Victor was commended for the high level of expertise and responsiveness provided on a significant syndicated deal worth $500 million for Abu Dhabi’s ZMI Holdings in December 2021
- Advising Genflow Biosciences plc (LON: GENF), the first pure-play longevity biotechnology firm to list in Europe, on a £3.7 million oversubscribed placing and the company’s admission to the standard segment of the main market of the London Stock Exchange
-
Languages
- Russian (fluent)
- French (fluent)
Victor Oliynik's Expertise
Commercial
We provide advice on a wide range of commercial agreements from trading agreements, outsourcing and other trading contracts and specialist projects. We have specialist experience in h...
Corporate
Delivering a high-quality combination of technical expertise, commercial acumen and excellent client service, our clients value the quality of our people, our market knowledge and our...
